Recommended Dietary Allowance (RDA) for Vitamin D: 400 IU/day
Dietary intake of antioxidant vitamins and mortality: a ...between dietary carotene, vitamin C, and...
Transcript of Dietary intake of antioxidant vitamins and mortality: a ...between dietary carotene, vitamin C, and...
Chronic Diseases Prevention Review 11 (2019) 20-32
Copyright@2019 by Chronic Diseases Prevention Review 20
Available at http:// www.cancercellresearch.org ISSN 2158-0820
Dietary intake of antioxidant vitamins and mortality: a meta-
analysis from large cohort studies
Yanyan Kang, Chongxiu Sun, Tianlin Gao* School of Public Health, Qingdao University, 266021, China
Abstract: The aim of the study was to assess the relationships between dietary intakes of antioxidant vitamins C, E and Vitamin A active substances (carotenes) with mortality in large cohort studies. Relevant English-language studies were identified though Medline, EMBASE, and web of science database till February 2018. Multivariate-adjusted risk ratios (RRs) for mortality in the highest verses the bottom category of baseline intake of antioxidant vitamins C, E and Vitamin A active substances (carotenes) were pooled using a fixed-effects meta-analysis and reported as relative risk (RR) with 95% confidence intervals (CIs). Meta-regression was used to assess the effect of covariates across the trials. Over the follow-up ranging from 3 to 32 years, 51,277 mortality events occurred among 419,837 adults from 14 cohort studies. Pooled relative risks comparing extreme carotene categories (high versus low) were 0.85 (95%CI, 0.80-0.91; P<0.001; I2=45.2%; Pheterogeneity=0.044) for total mortality, 0.83 (95% CI, 0.78-0.91; P<0.001; I2=23.5%; Pheterogeneity=0.258) in Eerope. Pooled relative risks comparing extreme vitamin C categories (high versus low) were 0.88 (95% CI, 0.81-0.95; P<0.001), with significant heterogeneity detected among studies (I2=87.5%; Pheterogeneity =0.0001).Vitamin E intake have no beneficial health effects 0.94 (95% CI, 0.80-1.00; P<0.001; I2=45.4%; Pheterogeneity=0.050). The present finding suggests that increased intake of vitamin C and carotene in diet may benefit prevention of death, but we do not find the evidence for higher intake of vitamin E was associated with the risk of death.
Keywords: Dietary; Antioxidant Vitamins; Mortality; Cohort Studies
Received 12 March 2019, Revised 26 May 2019, Accepted 28 May 2019
*Corresponding Author: Tianlin Gao, [email protected]
1. Introduction
There has been considerable interest in the role of
antioxidant vitamins in relation to risk of mortality.
Previous studies have showed an inverse association
of vegetable and fruit intakes and risk of all-cause
mortality[1,2]. However, whether this protective
effect is caused by antioxidant vitamins remains
unclear[3]. A series of studies have been conducted
in Western populations with good nutritional status,
which showed conflict results[4-9]. Based on the
evidence from epidemiologic research over the past
several decades, the effectiveness of antioxidant
vitamin intake on mortality should depend on
individual nutritional status[10]. However, few
studies have specifically examined the relation.
between dietary carotene, vitamin C, and vitamin E
and risk of all-cause mortality in population. We
aimed to access the relationship between dietary
carotene, vitamin C, and vitamin E intake and risk of
all cause mortality using data in large cohort studies.
2. Methods
2.1. Search Strategy
Our study followed the Meta-Analysis of
Observational Studies in Epidemiology
guidelines[11]. A literature search was performed in
Medline, EMBASE, and web of science for articles
published through February 15, 2018. We combined
search terms on exposure (antioxidant vitamins and
dietary intake and specific vitamins such as carotene,
vitamin C, and vitamin E) and outcomes (mortality
and cause of death) and (cohort studies or followed
studies) without language restriction. Details of the
search strategies are shown in the online-only Data
Supplement. Reference lists of retrieved articles were
scanned manually for additional studies.
2.2. Eligibility
Candidate articles were included if they met all of
the following criteria: They applied a prospective
cohort design; the exposure included intakes of WG
ingredients (with specified methods for calculation)
or WG foods (with specified food items); and the
outcome included mortality from all causes, CVD, or
cancer. For multiple sets of results published from
the same study population, we used results based on
the longest duration of follow-up.
2.3. Search and Data Extraction
Two authors (Yanyan Kang and Chongxiu Sun)
independently screened titles and abstracts of the
articles retrieved in the initial search, evaluated the
eligibility of the articles on the basis of a full text
review, and extracted data. Differences of opinions
were resolved by discussion among authors in order
to reach consensus. The following data were
extracted from each study: first author’s last name;
study location; year of publication; study period;
follow-up duration; number of participants; age;
amounts of food intake; methods of diet assessment;
number of deaths from all causes mortality; methods
of death confirmation; relative risks (RRs; measured
by hazard ratios in all individual studies) and
Chronic Diseases Prevention Review 11 (2019) 20-32
Copyright@2019 by Chronic Diseases Prevention Review 21
confidence intervals (CIs) for carotene, vitamin C
and vitamin E ; and covariates adjusted in
multivariable analysis. For studies reporting dietary
vitamins ingredient intake[12-16].
2.4. Statistical Analysis
Meta-analysis was based on risk estimates from
models with the most complete adjustment of
potential confounders but not components of
antioxidant vitamins such as dietary carotene,
vitamin C, and vitamin E. RRs comparing the highest
and lowest intake groups were summarized with a
random-effects model[17]. Statistical heterogeneity
was assessed with the Cochran Q test (P<0.10) and
statistic[18]. Analysis was stratified by study location
(United States, Europe, and other regions), genders.
In light of the limited number of included studies, we
performed univariate meta regressions to explore
whether these factors are potential sources of
heterogeneity. Publication bias was assessed by
funnel plot and the Egger linear regression test[19].
3. Results
Of the 3,217 records retrieved in the initial search,
1,180 were excluded after title and abstract screening,
and 1,046 were excluded after full-text search. We
further excluded 18 non-mortality reports based on
the same population, 24 reports that vitamins
supplementation was associated with existing
mortality, and 4 reports were not cohort studies
(Figure 1). 14 unique sets of results were included in
the meta-analysis, which included 419,837
participants, 51,277 total deaths (n=14). 10 studies
reported findings for vitamin C and mortality, 5
studies were conducted in US populations, 4 studies
were conducted in Europe populations, with the
remaining studies in China (n=1). 8 studies reported
findings for vitamin E and mortality. 10 studies
reported findings for carotene and mortality, with
total carotene (n=3) and β-carotene (n=4). Median
follow-up durations ranged from 3 to 32 years, and
study periods were between 1971 and 2012. Foods
accounting for dietary antioxidant vitamins intake
ranged from a single item in FFQs to a
comprehensive list of grain-based foods available
from 24-hour dietary recall (Table 1). The
association between dietary antioxidant vitamins
intake and mortality was the primary study aim of 14
investigations. Most studies applied FFQs to assess
dietary exposure (2 used FFQs and 3-days -24-hour
dietary recall, 7used baseline FFQs, 4 used 24-hour
dietary recall, and 1 used a diet history
questionnaire). Newcastle-Ottawa Scale scores
ranged from 7 to 9, with 10 studies scoring 8.
Figure 1. Flow diagram of study screening.
Chronic Diseases Prevention Review 11 (2019) 20-32
Copyright@2019 by Chronic Diseases Prevention Review 22
Figure 2. Dietary carotenes intake and mortality for the highest vs. lowest. all cause mortality(A),gender(B) and region(C)
in cohort studies. Cohort studies concerning dietary is referred to by first author, year of publication and number of
subjects, weighted and ranked according to the inverse of the variance of the logRR estimate. The relative risks (RRs)
are represented by the squares (the size is proportional to the weights used in the meta-analysis), and CIs are represented
by the error bars. P values for heterogeneity test (I square and Q test) and RR for the highest exposure quantile vs. lowest
from individual study were pooled by using random effect model.
NOTE: Weights are from random effects analysis
Overall (I-squared = 45.2%, p = 0.044)
Todd (1999)
Mursu (2011)
Study
Urszula Stepaniak (2016)
Roswall (2012)
ID
ZHAO (2016)
Todd (1999)
Pandey (1995)
ZHAO (2016)
Agudo (2007)
Urszula Stepaniak (2016)
Agudo (2007)
Genkinger (2004)
0.85 (0.80, 0.91)
0.87 (0.61, 1.24)
1.10 (0.93, 1.30)
0.86 (0.68, 1.08)
0.79 (0.73, 0.86)
ES (95% CI)
0.87 (0.80, 0.95)
1.07 (0.63, 1.82)
0.76 (0.62, 0.93)
0.83 (0.75, 0.91)
0.75 (0.59, 0.96)
0.99 (0.83, 1.18)
0.74 (0.58, 0.95)
0.81 (0.66, 1.00)
100.00
2.97
8.97
%
5.82
16.40
Weight
15.98
1.41
7.28
14.99
5.39
8.71
5.28
6.79
0.85 (0.80, 0.91)
0.87 (0.61, 1.24)
1.10 (0.93, 1.30)
0.86 (0.68, 1.08)
0.79 (0.73, 0.86)
ES (95% CI)
0.87 (0.80, 0.95)
1.07 (0.63, 1.82)
0.76 (0.62, 0.93)
0.83 (0.75, 0.91)
0.75 (0.59, 0.96)
0.99 (0.83, 1.18)
0.74 (0.58, 0.95)
0.81 (0.66, 1.00)
100.00
2.97
8.97
%
5.82
16.40
Weight
15.98
1.41
7.28
14.99
5.39
8.71
5.28
6.79
1.55 1 1.82
NOTE: Weights are from random effects analysis
.
.
.
Overall (I-squared = 87.5%, p = 0.000)
Subtotal (I-squared = 82.8%, p = 0.000)
Paganini-Hill (2015)
Pandey (1995)
Paganini-Hill (2015)
ALL
Study
Sahyoun (1996)
Mursu (2011)
Todd (1999)
male
ZHAO (2016)
ZHAO (2016)
female
Subtotal (I-squared = 89.7%, p = 0.000)
Urszula Stepaniak (2016)
Todd (1999)
Subtotal (I-squared = 80.7%, p = 0.000)
Urszula Stepaniak (2016)
Agudo (2007)
Roswall (2012)
Genkinger (2004)
ID
0.88 (0.81, 0.95)
0.86 (0.73, 1.01)
1.05 (0.98, 1.13)
0.68 (0.51, 0.91)
0.92 (0.87, 0.97)
0.55 (0.34, 0.88)
1.01 (0.97, 1.05)
0.68 (0.47, 0.99)
0.83 (0.75, 0.91)
0.83 (0.76, 0.90)
0.83 (0.68, 1.01)
0.92 (0.78, 1.09)
0.88 (0.47, 1.64)
0.92 (0.84, 1.01)
0.91 (0.71, 1.16)
0.74 (0.70, 0.79)
0.97 (0.89, 1.06)
0.95 (0.77, 1.17)
ES (95% CI)
100.00
34.27
10.02
4.34
10.42
%
2.21
10.61
3.20
9.38
9.72
28.24
7.33
1.41
37.49
5.32
10.22
9.62
6.19
Weight
0.88 (0.81, 0.95)
0.86 (0.73, 1.01)
1.05 (0.98, 1.13)
0.68 (0.51, 0.91)
0.92 (0.87, 0.97)
0.55 (0.34, 0.88)
1.01 (0.97, 1.05)
0.68 (0.47, 0.99)
0.83 (0.75, 0.91)
0.83 (0.76, 0.90)
0.83 (0.68, 1.01)
0.92 (0.78, 1.09)
0.88 (0.47, 1.64)
0.92 (0.84, 1.01)
0.91 (0.71, 1.16)
0.74 (0.70, 0.79)
0.97 (0.89, 1.06)
0.95 (0.77, 1.17)
ES (95% CI)
100.00
34.27
10.02
4.34
10.42
%
2.21
10.61
3.20
9.38
9.72
28.24
7.33
1.41
37.49
5.32
10.22
9.62
6.19
Weight
1.342 1 2.93
NOTE: Weights are from random effects analysis
.
.
.
Overall (I-squared = 45.2%, p = 0.044)
Urszula Stepaniak (2016)
Subtotal (I-squared = 54.3%, p = 0.087)
Subtotal (I-squared = 0.0%, p = 0.926)
Subtotal (I-squared = 33.6%, p = 0.210)
ZHAO (2016)
Mursu (2011)
Todd (1999)
Todd (1999)
Pandey (1995)
Agudo (2007)
Urszula Stepaniak (2016)
Agudo (2007)
ID
male
Genkinger (2004)
Study
female
ALL
Roswall (2012)
ZHAO (2016)
0.85 (0.80, 0.91)
0.86 (0.68, 1.08)
0.94 (0.82, 1.09)
0.78 (0.73, 0.84)
0.86 (0.77, 0.95)
0.87 (0.80, 0.95)
1.10 (0.93, 1.30)
1.07 (0.63, 1.82)
0.87 (0.61, 1.24)
0.76 (0.62, 0.93)
0.75 (0.59, 0.96)
0.99 (0.83, 1.18)
0.74 (0.58, 0.95)
ES (95% CI)
0.81 (0.66, 1.00)
0.79 (0.73, 0.86)
0.83 (0.75, 0.91)
100.00
5.82
32.18
33.87
33.96
15.98
8.97
1.41
2.97
7.28
5.39
8.71
5.28
Weight
6.79
%
16.40
14.99
0.85 (0.80, 0.91)
0.86 (0.68, 1.08)
0.94 (0.82, 1.09)
0.78 (0.73, 0.84)
0.86 (0.77, 0.95)
0.87 (0.80, 0.95)
1.10 (0.93, 1.30)
1.07 (0.63, 1.82)
0.87 (0.61, 1.24)
0.76 (0.62, 0.93)
0.75 (0.59, 0.96)
0.99 (0.83, 1.18)
0.74 (0.58, 0.95)
ES (95% CI)
0.81 (0.66, 1.00)
0.79 (0.73, 0.86)
0.83 (0.75, 0.91)
100.00
5.82
32.18
33.87
33.96
15.98
8.97
1.41
2.97
7.28
5.39
8.71
5.28
Weight
6.79
%
16.40
14.99
类胡萝卜素与死亡亚组分析——性别
1.55 1 1.82
C
B
A
Chronic Diseases Prevention Review 11 (2019) 20-32
Copyright@2019 by Chronic Diseases Prevention Review 23
Figure 3. dietary vitamin C intake and mortality for the highest vs. lowest. All cause mortality(A)and region(B) in cohort
studies. Cohort studies concerning dietary is referred to by first author, year of publication and number of subjects,
weighted and ranked according to the inverse of the variance of the logRR estimate. The relative risks (RRs) are
represented by the squares (the size is proportional to the weights used in the meta-analysis), and CIs are represented by
the error bars. P values for heterogeneity test (I square and Q test) and RR for the highest exposure quantile vs. lowest
from individual study were pooled by using random effect model.
A A A A
B
Chronic Diseases Prevention Review 11 (2019) 20-32
Copyright@2019 by Chronic Diseases Prevention Review 24
Figure 4. dietary vitamin C intake and mortality for the highest vs. lowest. All cause mortality(A),gender(B) and
region(C) in cohort studies. Cohort studies concerning dietary is referred to by first author, year of publication and
number of subjects, weighted and ranked according to the inverse of the variance of the logRR estimate. The relative
risks (RRs) are represented by the squares (the size is proportional to the weights used in the meta-analysis), and CIs are
represented by the error bars. P values for heterogeneity test (I square and Q test) and RR for the highest exposure
quantile vs. lowest from individual study were pooled by using random effect model.
NOTE: Weights are from random effects analysis
Overall (I-squared = 45.4%, p = 0.050)
Roswall (2012)
Urszula Stepaniak (2016)
Todd (1999)
Todd (1999)
ID
Urszula Stepaniak (2016)
ZHAO (2016)
Stampfer (1993)
Study
Mursu (2011)
Agudo (2007)
ZHAO (2016)
Genkinger (2004)
0.94 (0.89, 1.00)
0.85 (0.77, 0.93)
0.85 (0.67, 1.08)
0.91 (0.63, 1.31)
1.26 (0.71, 2.24)
ES (95% CI)
1.08 (0.92, 1.27)
0.91 (0.84, 0.99)
0.95 (0.73, 1.24)
1.01 (0.97, 1.06)
0.83 (0.64, 1.08)
0.95 (0.86, 1.05)
0.98 (0.80, 1.20)
100.00
15.42
4.66
2.21
0.94
Weight
8.45
17.01
3.85
%
22.67
4.00
14.55
6.25
0.94 (0.89, 1.00)
0.85 (0.77, 0.93)
0.85 (0.67, 1.08)
0.91 (0.63, 1.31)
1.26 (0.71, 2.24)
ES (95% CI)
1.08 (0.92, 1.27)
0.91 (0.84, 0.99)
0.95 (0.73, 1.24)
1.01 (0.97, 1.06)
0.83 (0.64, 1.08)
0.95 (0.86, 1.05)
0.98 (0.80, 1.20)
100.00
15.42
4.66
2.21
0.94
Weight
8.45
17.01
3.85
%
22.67
4.00
14.55
6.25
vitamin E and motality
1.446 1 2.24
NOTE: Weights are from random effects analysis
.
.
.
Overall (I-squared = 45.4%, p = 0.050)
Urszula Stepaniak (2016)
Subtotal (I-squared = 0.0%, p = 0.382)
Agudo (2007)
Todd (1999)
female
Urszula Stepaniak (2016)
Subtotal (I-squared = 42.8%, p = 0.136)
ZHAO (2016)
Genkinger (2004)
ID
Study
Mursu (2011)
ALL
ZHAO (2016)
Roswall (2012)
Subtotal (I-squared = 0.0%, p = 0.419)
Stampfer (1993)
Todd (1999)
male
0.94 (0.89, 1.00)
0.85 (0.67, 1.08)
0.98 (0.90, 1.06)
0.83 (0.64, 1.08)
0.91 (0.63, 1.31)
1.08 (0.92, 1.27)
0.96 (0.89, 1.04)
0.91 (0.84, 0.99)
0.98 (0.80, 1.20)
ES (95% CI)
1.01 (0.97, 1.06)
0.95 (0.86, 1.05)
0.85 (0.77, 0.93)
0.87 (0.80, 0.94)
0.95 (0.73, 1.24)
1.26 (0.71, 2.24)
100.00
4.66
25.20
4.00
2.21
8.45
49.13
17.01
6.25
Weight
%
22.67
14.55
15.42
25.67
3.85
0.94
0.94 (0.89, 1.00)
0.85 (0.67, 1.08)
0.98 (0.90, 1.06)
0.83 (0.64, 1.08)
0.91 (0.63, 1.31)
1.08 (0.92, 1.27)
0.96 (0.89, 1.04)
0.91 (0.84, 0.99)
0.98 (0.80, 1.20)
ES (95% CI)
1.01 (0.97, 1.06)
0.95 (0.86, 1.05)
0.85 (0.77, 0.93)
0.87 (0.80, 0.94)
0.95 (0.73, 1.24)
1.26 (0.71, 2.24)
100.00
4.66
25.20
4.00
2.21
8.45
49.13
17.01
6.25
Weight
%
22.67
14.55
15.42
25.67
3.85
0.94
1.446 1 2.24
NOTE: Weights are from random effects analysis
.
.
.
Overall (I-squared = 45.4%, p = 0.050)
ZHAO (2016)
Roswall (2012)
Subtotal (I-squared = 0.0%, p = 0.514)
Genkinger (2004)
Subtotal (I-squared = 0.0%, p = 0.873)
Mursu (2011)
Todd (1999)
Asia
America
Stampfer (1993)
Urszula Stepaniak (2016)
ZHAO (2016)
ID
Todd (1999)
Urszula Stepaniak (2016)
erope
Subtotal (I-squared = 39.4%, p = 0.143)
Agudo (2007)
Study
0.94 (0.89, 1.00)
0.91 (0.84, 0.99)
0.85 (0.77, 0.93)
0.93 (0.87, 0.99)
0.98 (0.80, 1.20)
1.01 (0.96, 1.05)
1.01 (0.97, 1.06)
0.91 (0.63, 1.31)
0.95 (0.73, 1.24)
1.08 (0.92, 1.27)
0.95 (0.86, 1.05)
ES (95% CI)
1.26 (0.71, 2.24)
0.85 (0.67, 1.08)
0.92 (0.82, 1.03)
0.83 (0.64, 1.08)
100.00
17.01
15.42
31.56
6.25
32.77
22.67
2.21
3.85
8.45
14.55
Weight
0.94
4.66
35.68
4.00
%
0.94 (0.89, 1.00)
0.91 (0.84, 0.99)
0.85 (0.77, 0.93)
0.93 (0.87, 0.99)
0.98 (0.80, 1.20)
1.01 (0.96, 1.05)
1.01 (0.97, 1.06)
0.91 (0.63, 1.31)
0.95 (0.73, 1.24)
1.08 (0.92, 1.27)
0.95 (0.86, 1.05)
ES (95% CI)
1.26 (0.71, 2.24)
0.85 (0.67, 1.08)
0.92 (0.82, 1.03)
0.83 (0.64, 1.08)
100.00
17.01
15.42
31.56
6.25
32.77
22.67
2.21
3.85
8.45
14.55
Weight
0.94
4.66
35.68
4.00
%
1.446 1 2.24
C
B
A
Chronic Diseases Prevention Review 11 (2019) 20-32
Copyright@2019 by Chronic Diseases Prevention Review 25
Figure 2(A) shows forest plots on mortality,
comparing the highest and lowest groups of carotene.
The pooled RR for total mortality was 0.85 (95% CI,
0.80-0.91; P<0.001), with significant heterogeneity
detected among studies (I2=45.2%;
Pheterogeneity=0.044). Figure 2(B) shows forest plots on
mortality, comparing the highest and lowest groups
of carotene in different regions. The pooled RR for
total mortality in US was 0.88 (95% CI, 0.70-1.12; P
< 0.001), with significant heterogeneity detected
among studies (I2=78.5%; Pheterogeneity=0.009). Figure
2(C) shows forest plots on mortality, comparing the
highest and lowest groups of carotene in male and
female. The pooled RR for total mortality in female
was 0.94 (95% CI, 0.81-1.19; P<0.001), with
significant heterogeneity detected among studies
(I2=54.3%; Pheterogeneity =0.087). Results of stratified
analysis are shown with significantly lower RRs
observed in most subgroups. Funnel plots for
publication bias are shown in Figure I. The Egger
test did not suggest publication bias for total
mortality.
Figure 3(A) shows forest plots on mortality,
comparing the highest and lowest groups of vitamin
C. The pooled RR for total mortality was 0.88 (95%
CI, 0.81-0.95; P<0.001), with significant
heterogeneity detected among studies (I2=87.5%;
Pheterogeneity=0.0001). Figure 2(B) shows forest plots
on mortality, comparing the highest and lowest
groups of carotene in different regions. The pooled
RR for total mortality in US was 0.95 (95% CI, 0.87-
1.03; P < 0.001), with significant heterogeneity
detected among studies (I2=78.5%;
Pheterogeneity=0.0001). The pooled RR for total
mortality in Europe was 0.85 (95% CI, 0.83-0.99; P
< 0.001), with significant heterogeneity detected
among studies (I2=82.3%; Pheterogeneity=0.0001).
Figure 4(A) shows forest plots on mortality,
comparing the highest and lowest groups of carotene.
The pooled RR for total mortality was 0.94 (95% CI,
0.80-1.00; P<0.001), with significant heterogeneity
detected among studies (I2=45.4%;
Pheterogeneity=0.050). Figure 2(B) shows forest plots on
mortality, comparing the highest and lowest groups
of carotene in different genders. The pooled RR for
total mortality female was 0.98 (95% CI, 0.89-1.04;
P<0.001), with significant heterogeneity detected
among studies (I2=42.8%; Pheterogeneity=0.138). The
pooled RR for total mortality in male was 0.94 (95%
CI, 0.90-1.08; P < 0.001), with significant
heterogeneity detected among studies (I2=0%;
Pheterogeneity=0.382). Figure 2(C) shows forest plots on
mortality, comparing the highest and lowest groups
of carotene in different genders. The pooled RR for
total mortality in Europe was 0.92 (95% CI, 0.82-
1.03; P< 0.001), with significant heterogeneity
detected among studies (I2=39.4%;
Pheterogeneity=0.143). The pooled RR for total mortality
in the US was 1.01 (95% CI, 0.98-1.05; P<0.001),
with significant heterogeneity detected among
studies (I2=0%; Pheterogeneity=0.873).
4. Discussion
The analysis of carotene and the relationship for
all-cause mortality found that dietary intake of
carotenoids can reduce all-cause mortality, Similar
association patterns were observed in subgroup and
sensitivity analyses, there may be related to regional
differences and gender differences, in Europe the
study found that dietary intake of high carotene can
reduce all-cause death, but there was no relationship
in the US; intake higher carotene can reduce the all-
cause mortality of female, but no effect for male.
Dietary vitamin C can reduce all-cause mortality. In
female, dietary vitamin C has a protective effect on
death, while dietary vitamin C in men and mixed
gender groups has no effect on death. In Europe,
dietary vitamin C was associated with a protective
effect against death, while dietary vitamin C was not
associated with death in the US. Dietary vitamin E
was not associated with all-cause death. The ability
of antioxidant vitamins, such as carotene and vitamin
C, to prevent oxidative damage is thought to be
involved in the pathological process of many chronic
diseases. In previous studies, the lack of association
between vitamin intake and mortality may be due to
the study of well-nourished cohort members[17-34].
For poorly nourished populations, previous studies
have suggested beneficial effects of antioxidant
vitamins in relation to mortality[31]. We found a
non-linear relationship of total carotene and vitamin
C intake with mortality in men. Antioxidant vitamins
in the human body may need to be maintained within
a narrow concentration range for normal
physiological functioning[35].
some large, prospective cohort studies have found
significantly lower mortality with vitamin intake,
supplemental A, C, or E in women, dietary C, dietary
A or β-carotene, and total C. 17-19, 23 those studies
have not found the relationship between dietary
antioxidants and mortality.19,24-27 Many of these
studies, which were carried out in diverse
populations (United States, Europe, Sweden,
Japan)[17-30], in both younger and older adults, and
in both men and women, included adjustment for
various potential confounders. Generally such
adjustment attenuated the risks of all-cause mortality
observed with only age and sex adjustment. Some
studies suggest that confounders or chance might
account for the positive associations between vitamin
intake and mortality observed in some previous
prospective studies[33]. But a meta-analysis of all
large cohorts of dietary antioxidant vitamins and all-
cause mortality could explain the observed
phenomenon. Increased dietary intake of vitamin C
and carotene can reduce all-cause mortality, which
may vary regionally. Studies in the United States
have shown that dietary antioxidant vitamin intake is
Chronic Diseases Prevention Review 11 (2019) 20-32
Copyright@2019 by Chronic Diseases Prevention Review 26
not associated with all-cause mortality. Dietary
vitamin E intake may not be associated with all-
cause death.
The inverse association between vitamin C and
mortality was in accordance with a previous study in
Japan[35]. For dietary carotene, three prospective
studies found that carotene was associated with all
cause mortality, with a reduction of ten to thirty
percent[12, 22, 28]. A prospective study observed
dietary vitamin C or carotene intake may confound
the mortality-vitamin E association[33]. Of all the
studies exploring the associations of dietary
antioxidant vitamins with risk of mortality, only one
study was conducted in Asia[35-38]. Some studies
conducted in the US or Europe contended that the
lack of association between vitamin intake and
mortality was due to the population was well-fed[8,
27]. Additional vitamin E intake may have no
beneficial health effects.
Strengths of the present study include a large
number of participants in original studies and careful
hierarchical analysis. According to sensitivity
analyses, findings were independent of differences in
antioxidant vitamins assessment methods.
Meanwhile, our study has some limitations. First, in
this study, the dose relationship between dietary
intake of antioxidant vitamins and all-cause death
was insufficient. If the relationship between different
causes of death and antioxidant vitamins could be
stratified, there would be stronger evidence to prove
the relationship between dietary vitamins and death.
Therefore, results must be interpreted with caution.
Additionally, we cannot exclude we did dietary
supplements and their intake and death, so we can
only explain the relationship between low-dose
antioxidant vitamins and all-cause death.
5. Conclusion
The present finding suggests that increased intake
of vitamin C and carotenes in diet may benefit
prevention of death, but we do not find the evidence
for higher intake of vitamin E was associated with
the risk of death.
References
[1] Okuda N, Miura K, Okayama A, et al. Fruit
and vegetable intake and mortality from
cardiovascular disease in Japan: a 24-year
follow-up of the NIPPON DATA80 Study[J].
European Journal of Clinical Nutrition, 2015,
69(4):482-488.
[2] Wang X, Ouyang Y, Liu J, et al. Fruit and
vegetable consumption and mortality from all
causes, cardiovascular disease, and cancer:
systematic review and dose-response meta-
analysis of prospective cohort studies[J]. Bmj
British Medical Journal, 2014, 349(jul29
3):g4490.
[3] Genkinger JM, Platz EA, Hoffman SC, et al.
Fruit, Vegetable, and antioxidant intake and
all-cause, cancer, and cardiovascular disease
mortality in a community-dwelling
population in washington county,
maryland[J]. American Journal of
Epidemiology, 2004, 160(12):1223-1233.
[4] Paganinihill A, Kawas CH, Corrada MM.
Antioxidant vitamin intake and mortality: the
Leisure World Cohort Study[J]. American
Journal of Epidemiology, 2015, 181(2):120-
126.
[5] Henriquez-Sanchez P, Sanchez-Villegas A,
Ruano-Rodriguez C, et al. Dietary total
antioxidant capacity and mortality in the
PREDIMED study[J]. Eur J Nutr. 2016,
55:227-236.
[6] Kubota Y, Iso H, Date C, et al. Dietary
intakes of antioxidant vitamins and mortality
from cardiovascular disease: the Japan
collaborative cohort study (JACC) study[J].
Stroke. 2011, 42:1665-1672.
[7] Buijsse B, Feskens EJM, Kwape L, et al.
Both alpha- and betacarotene, but not
tocopherols and vitamin C, are inversely
related to 15-year cardiovascular mortality in
Dutch elderly men[J]. J Nutr. 2008, 138:344-
350.
[8] Bates CJ, Hamer M, Mishra GD. Redox-
modulatory vitamins and minerals that
prospectively predict mortality in older
British people: the national diet and nutrition
survey of people aged 65 years and over[J].
Br J Nutr. 2011, 105:123-132.
[9] Stepaniak U, Micek A, Grosso G, et al.
Antioxidant vitamin intake and mortality in
three central and eastern European urban
populations: the HAPIEE study[J]. Eur J Nutr.
2016, 55:547-560.
[10] Goyal A, Terry MB, Siegel AB. Serum
antioxidant nutrients, vitamin A, and
mortality in U.S. adults. Cancer Epidemiol
Biomarkers Prev. 2013, 22:2202-2211
[11] Stroup DF, Berlin JA, Morton SC, et al.
Meta-analysis of observational studies in
epidemiology: a proposal for reporting:
Meta-analysis Of Observational Studies in
Epidemiology (MOOSE) group[J]. JAMA.
2000, 283:2008-2012.
[12] Jacobs DR, Meyer HE, Solvoll K. Reduced
mortality among whole grain bread eaters in
men and women in the Norwegian County
Study[J]. Eur J Clin Nutr. 2001, 55:137-143.
Sahyoun NR, Jacques PF, Zhang XL, et al.
Wholegrain intake is inversely associated
with the metabolic syndrome and mortality in
older adults[J]. Am J Clin Nutr. 2006,
83:124-131.
Jacobs DR Jr, Andersen LF, Blomhoff R.
Whole-grain consumption is associated with
Chronic Diseases Prevention Review 11 (2019) 20-32
Copyright@2019 by Chronic Diseases Prevention Review 27
a reduced risk of noncardiovascular,
noncancer death attributed to inflammatory
diseases in the Iowa Women’s Health
Study[J]. Am J Clin Nutr. 2007, 85:1606-
1614.
Huang T, Xu M, Lee A, et al. Consumption
of whole grains and cereal fber and total and
cause-specifc mortality: prospective analysis
of 367,442 individuals[J]. BMC Med. 2015,
13:59.
Johnsen NF, Frederiksen K, Christensen J,
et al. Whole-grain products and whole-grain
types are associated with lower allcause and
cause-specifc mortality in the Scandinavian
HELGA cohort[J]. BrJ Nutr. 2015, 114:608-
623.
[13] Lau J, Ioannidis JP, Schmid CH. Quantitative
synthesis in systematic reviews[J]. Ann
Intern Med. 1997, 127:820-826.
[14] Higgins JP, Thompson SG. Quantifying
heterogeneity in a meta-analysis[J]. Stat Med.
2002, 21:1539-1558.
Egger M, Davey Smith G, Schneider M,
Minder C. Bias in meta-analysis detected by
a simple, graphical test[J]. BMJ. 1997,
315:629-634.
[15] Enstrom, JE, Kanim LE, Klein MA. Vitamin
C intake and mortality among a sample of the
United States population[J]. Epidemiology,
1992, 3(3):194-202.
[16] Stampfer MJ, Hennekens CH, Manson JAE,
et al. Vitamin E Consumption and the Risk of
Coronary Disease in Women[J]. New
England Journal of Medicine, 1993,
328(20):1444-1449.
[17] Pandey DK, Shekelle R, Selwyn BJ, et al.
Dietary vitamin C and beta-carotene and risk
of death in middle-aged men. The Western
Electric Study[J]. American Journal of
Epidemiology, 1995, 142(12):1269-1278.
[18] Sahyoun N. Carotenoids, vitamins C and E,
and mortality in an elderly population[J]. Am
J Epidemiol, 1996, 144(5):501-11.
[19] Hankey GJ. Nutrition and the risk of
stroke[J]. Lancet Neurology, 2012, 11(1):66-
81.
[20] Khaw KT, Bingham S, Welch A, et al.
Relation between plasma ascorbic acid and
mortality in men and women in EPIC-
Norfolk prospective study: a prospective
population study. European Prospective
Investigation into Cancer and Nutrition[J].
Lancet (London, England), 2001,
357(9257):657-663.
[21] Hopkins M H, Fedirko V, Jones D P, et al.
Antioxidant micronutrients and biomarkers
of oxidative stress and inflammation in
colorectal adenoma patients: results from a
randomized, controlled clinical trial[J].
Cancer Epidemiol Biomarkers Prev, 2010,
19(3):850-858.
[22] Agudo A, Cabrera L, Amiano P, et al. Fruit
and vegetable intakes, dietary antioxidant
nutrients, and total mortality in Spanish
adults: findings from the Spanish cohort of
the European Prospective Investigation into
Cancer and Nutrition (EPIC-Spain)[J]. The
American Journal of Clinical Nutrition, 2007,
85(6):1634-1642.
[23] Buijsse B, Feskens E J M, Kwape L, et al.
Both alpha- and beta-carotene, but not
tocopherols and vitamin C, are inversely
related to 15-year cardiovascular mortality in
Dutch elderly men[J]. Journal of Nutrition,
2008, 138(2):344-350.
[24] Kubota Y, Iso H, Date C, et al. Dietary
intakes of antioxidant vitamins and mortality
from cardiovascular disease: the Japan
Collaborative Cohort Study (JACC) study[J].
Stroke, 2011, 42(6):1665-1672.
[25] Roswall N, Olsen A, Christensen J, et al.
Micronutrient intake in relation to all-cause
mortality in a prospective Danish cohort[J].
Food & Nutrition Research, 2012, 56.
[26] Paganinihill A, Kawas CH, Corrada MM.
Antioxidant vitamin intake and mortality: the
Leisure World Cohort Study[J]. American
Journal of Epidemiology, 2015, 181(2):120-
126.
[27] PaganiniHill A, Kawas CH, Corrada MM.
Antioxidant vitamin intake and mortality in
three Central and Eastern European urban
populations: the HAPIEE study[J]. European
Journal of Nutrition, 2016, 55(2):547-560.
[28] Zhao LG, Shu XO, Li HL, et al. Dietary
antioxidant vitamins intake and mortality: A
report from two cohort studies of Chinese
adults in Shanghai[J]. Journal of
Epidemiology, 2017, 27(3):89-97.
[29] Wells GA SB, O’Connell D, Peterson J, et al.
The Newcastle-Ottawa Scale (NOS) for
assessing the quality of nonrandomized
studies in meta-analysis. 2011.
www.ohri.ca/programs/clinical_epidemiolog
y/oxford.asp. Accessed August 12, 2013.
[30] Desquilbet L, Mariotti F. Dose-response
analyses using restricted cubic spline
functions in public health research[J].
Statistics in Medicine, 2010, 29(9):1037-
1057.
[31] Kubota Y, Iso H, Date C, et al. Dietary
intakes of antioxidant vitamins and mortality
from cardiovascular disease: the Japan
Collaborative Cohort Study (JACC) study[J].
Stroke, 2011, 42(6):1665-1672.
[32] Bates CJ, Mark H, Mishra GD. Redox-
modulatory vitamins and minerals that
prospectively predict mortality in older
British people: the National Diet and
Nutrition Survey of people aged 65 years and
Chronic Diseases Prevention Review 11 (2019) 20-32
Copyright@2019 by Chronic Diseases Prevention Review 28
over[J]. British Journal of Nutrition, 2011,
105(1):10.
[33] Sahyoun N. Carotenoids, vitamins C and E,
and mortality in an elderly population[J]. Am
J Epidemiol, 1996, 144:501-511.
Chronic Diseases Prevention Review 11 (2019) 20-32
Copyright@2019 by Chronic Diseases Prevention Review 29
Table 1. Characteristics of Studies Included in the Meta-Analysis
Sample
Age in years
Design Duration
period(year
s)
Dietary assessment Case of death
number
Exposure Outcomes
(RRs,95% CI)
Covariates
Measurement Range(H vs. L)a
Enstron
1992,USA20
NHANES Ia
11,348 adults age 15
to 74
Prospective
Study
10(1972-
1984)
24-Hour dietary
recall and FFQ
ACM:1,809
Males:1069
Females:740
Vitamin C(mg/d) 129
vs. U.S.White
Males:0.93(.084,1.02)
Females:0.93(.083,1.03)
Both sexes:0.93(.087,1.00)
Age and sex.
Stampfer
1993,USA21
87,245 femal
nurses,34 to 59
Prospective
Study
8(1980-
1988)
FFQ CVD:552 Vitamin
E(IU/day)
2.6 vs. 7.7 0.95(0.72,1.23) Age and smoking.
Pandey
1995,USA22
The Western
Electric Study
1,556 middle aged
men, 40 to 55
Prospective
Study
24(1959-
1983)
28-day diet
histories
552
Vitamin C(mg/d) Increment 100mg/d
intake of Vitamin C
0.71(0.46,1.09)
Age,systolic blood pressure, body mass
index, serum cholesterol, cigarette
smoking(where appropriate), family history
of cardiovascular disease, alcohol
consumption, and dietary intake of energy,
cholesterol, iron, saturated fatty acids, and
polyunsaturated fatty acids.
Beta-
cartotene(mg/d)
Increment 3mg/d intake
of Beta-cartotene
0.76(0.63,0.92)
Sahyoun
1995,USA23
747 elderly
population aged 60
to 101
Prospective
Study
9-12(1981-
1993)
3-day food record 217
Vitamin C ACM:0.55(0.34,0.88) Age, sex, serum cholesterol, disease status,
and disabilities affecting shopping. Vitamin E _ ACM:0.83(0.54,1.27
Todd 1999,UK24
Scottish Heart
Health Study,
11,629, 40 to 59
Prospective
Study
7.7(1984-
1993)
Semiquantitative
FFQ
591
Vitamin
C(mg/4.18MJ)
Males:15.6 vs. 18.9
Females:18.6 vs. 18.2
Males:0.68(0.46,1.01)
Females:0.88(0.47,1.63)
Age, serum total cholesterol, systolic btood
pressure, carbon monoxide, energy, previous
medical diagnosis of diabetes, body mass
index, the
Bortner personality score, triglycerides, high
density lipoprotein cholesterol, fibrinogen, a
self-reported measure of activity in leisure,
and alcohol consumption.
Vitamin
E(mg/4.18MJ)
Males:1.9 vs. 3.3
Females:12.3 vs. 3.7
Males:0.91(0.63,1.31)
Females:1.28(0.72,2.28)
Beta-
carotene(μg/4.18
MJ)
Males:692.8 vs. 1,933.6
Females:1978 vs.
2,704.5
males:0.87(0.61,1.23)
Females:1.07(0.63,1.82)
Chronic Diseases Prevention Review 11 (2019) 20-32
Copyright@2019 by Chronic Diseases Prevention Review 30
Khaw 2001,UK25
EPICb-Norfolk
19,496, 45 to 79
Prospective
Study
4(1993-
1997)
7-day diet diary ACM:496
Vitamin C(mg/d) Males:
51 vs.109
0.77(0.67,0.87) Age, systolic blood pressure, cholesterol,
body mass index (continuous variables);
cigarette smoking habit, diabetes mellitus,
any supplement use.
Females:
57 vs. 113
:0.85(0.73,0.99)
Genkinger
2004,USA26
Odyssey Cohort, 6,
151,30 to 93
Prospective
Study
13(1989-
2002)
FFQ ACM:910
Vitamin C(mg/d) 39.4 vs. 175.6 ACM:0.95(0.77,1.17) Age, smoking status, body mass index,
cholesterol concentration, and energy.
Vitamin E(mg/d) 5.1 vs. 12.4 ACM:0.98(0.80,1.19)
Beta-
carotene(μg/d)
679.2 vs. 3884.8 ACM:0.81(0.66,1.00)
Agudo 2007,
Spanic27
EPICb-Spain, 41,358
subjects aged 30 to
69 y.
Prospective
Study
6.6(1992-
1996)
Computerized
questionnaire
ACM:256
Vitamin C
(mg/d)
96.9 vs. 261.3 0.74 (0.58, 0.94) Age (time axis), sex, total energy intake,
education, BMI, physical activity,
cigarette smoking, and alcohol consumption.
Vitamin E(mg/d) 6.1 vs.19.1 0.83 (0.64, 1.08)
Provitamin Ac
(μg/d)
1224.9 vs. 3210.8 0.68 (0.53, 0.87)
Buijsse 2008,
Dutch 28
The Zutphen Elderly
Study, In 1985, 559
men (mean age 72
y)
Prospective
Study
15(1985-
2000)
Cross-check
dietary history
CVD:197 Total
carotenoids(μg/d
)
6372±3,201 0.90(0.77,1.06) Adjusted RR for 1-SD;
Adjusted for age, energy intake, and lifestyle
not including dietary factors.
Beta-
carotene(μg/d)
2766±1,474 0.88(0.74,1.05)
Vitamin C(mg/d) 88±38 0.91(0.78,1.07)
Vitamin E(mg/d) 12.5±11.9 0.92(0.78,1.09)
Chronic Diseases Prevention Review 11 (2019) 20-32
Copyright@2019 by Chronic Diseases Prevention Review 31
Kubota
2011,Japan29
The Japan
Collaborative
Cohort Study,
23,119 men and
35,611 women aged
40 to 79 years
Prospective
Study
16.5(1988-
2006)
FFQ
CVD:2,690
Male:1343
Female:1347
Male:
Vitamin A(μg/d)
270 vs. 1439 1.09(0.90,1.33) age, history of hypertension and diabetes,
smoking status, alcohol consumption, body
mass index, mental stress, walking, sports,
education levels, dietary intakes of total
energy, cholesterol, saturated fatty acids, n-3
fatty acids, and sodium.
Vitamin C(mg/d) 52 vs. 145 0.88(0.72,1.07)
Vitamin E(mg/d) 3.6 vs. 6.6 0.91(0.69,1.22)
Female:
Vitamin A(μg/d)
290 vs. 1,391 1.04(0.85,1.26)
Vitamin C(mg/d) 65 vs. 150 0.82(0.65,1.04)
Vitamin E(mg/d) 3.8 vs. 6.4 0.79(0.66,0.94)
Roswall 2012,
Danish30
55,453 middle-aged
Danes, aged 50 to
64y
Prospective
Study
13.8(1993-
2010)
FFQ ACM:6,767 Vitamin C(mg/d) ≤65.19 vs. >127.75 0.97(0.89,1.06) Total intake of the three other micronutrients
as well as dietary intake for the supplemental
intake and supplemental intake for the dietary
intake and further for alcohol intake, BMI,
waist circumference, smoking status,
smoking duration, smoking intensity, time
since
cessation, education, and physical activity.
Vitamin E(mg/d) ≤6.51vs. >10.60 0.85(0.78,0.94)
Beta-
carotene(μg/d)
≤1317.07vs. >4797.69 0.79(0.73,0.86)
Paganini-Hill
2014, U.S. 31
8,640 women and
4,983 men (median
age at entry, 74
years)
Prospective
Study
32(1981-
2013)
FFQ ACM:13,104
Male:4878
Vitamin A(IU/d) <8000 vs. ≥16,333 Male:1.00(0.93,1.07)
Female:0.99(0.93,1.04)
Age, smoking, body mass index, exercise,
alcohol intake, caffeine consumption, and
histories of hypertension, angina, heart
attack, stroke, diabetes, rheumatoid arthritis,
and cancer.
Vitamin C(mg/d) <155 vs. ≥225 Male:1.05(0.98,1.13)
Female: 0.97(0.92,1.02)
Chronic Diseases Prevention Review 11 (2019) 20-32
Copyright@2019 by Chronic Diseases Prevention Review 32
Stepaniak 2015,32
European
The HAPIEEd study,
28,945 men and
women aged 45-69
years
Prospective
Study
6.5-
8.1(2002-
2011)
FFQ ACM:2,371;
male:1590
Cancer:830;
male:527
CVD:997;
male:684
Vitamin C(mg/d) Male:51.1 vs. 231.3 ACM:0.92(0.78,1.09) age, country, education, smoking status,
alcohol intake, BMI, hypertension, diabetes,
hypercholesterolemia, history of CVD or
cancer, total energy intake.
Female:59.3 vs. 308.2 ACM:0.91(0.71,1.16)
Vitamin E(mg/d) Male:5.9 vs. 12.2 ACM:1.08(0.92,1.27)
Female:6.6 vs. 14.1 ACM:0.85(0.67,1.08)
Beta-
carotene(μg/d)
Male:2897.2 vs.
12,730.7
ACM:0.99(0.83,1.17)
Female:3446.9 vs.
15,033.9
ACM:0.86(0.68,1.08)
Zhao 2016,
China(Male)33
59,739 (mean
age:64)
Prospective
Study
8.3(2002-
2012)
FFQ and 24-h
dietary recalls
ACM:4170
Cancer:1789
CVD:1379
Vitamin C(mg/d) 44.55 vs. 151.69 ACM:0.83(0.75,0.91) Age, energy, birth cohort, education, income,
occupation
, smoking status, alcohol intake, body mass
index, waist-hip ratio, physical activity,
history of hypertension, diabetes, coronary
heart disease, stroke, vitamin supplements
use,menopause status, hormone
replacement therapy.
Vitamin E(mg/d) 8.85 vs. 20.91 ACM:0.95(0.86,1.05)
Total
carotene(μg/d)
1392.62 vs. 5099.66 ACM:0.83(0.76,0.92)
Zhao 2016,
China(Female)33
74,619(mean age:
61)
14.2(1997-
2012)
Female:5909
Cancer:2595
CVD:1819
Vitamin C(mg/d) 42.51 vs. 142.72 ACM:0.83(0.77,0.91)
Vitamin E(mg/d) 8.19 vs. 18.48 ACM:0.91(0.84,0.99)
Total
carotene(μg/d)
1333.63 vs. 4602.66 ACM:0.87(0.80,0.95)
a NHANES I: the First National Health and Nutrition Examination Survey
b EPIC: European Prospective Investigate into Cancer and Nutrition
c As beta-carotene equivalents: beta-carotene +0.5 * Alpha-carotene + 0.53 * beta-cryptoxanthin.
d The HAPIEE study: The Health, Alcohol and Psychosocial factors in Eastern Europe (HAPIEE) study